4
Changes in Ownership
LB PHARMACEUTICALS INC Filed Acc 0002095250-25-000006
Options or other derivatives
- Chief Commercial Officer acquired 195,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Pai Panandiker Kaya Kamlesh Chief Commercial Officer | 2025-12-10 | Grant or award · Employee Stock Option (Right to Buy) | +195,000 | 195,000 | D | ||
Loading xslF345X05/form4-12112025_041206.xml…